Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ABBV compared with BMY: revenue, margins and what each company keeps, and the suppliers and customers both name
ABBV
AbbVie Inc.
Change
Mkt cap
Revenue
Revenue
BMY
Bristol Myers Squibb Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
ABBV
AbbVie Inc.
vs
BMY
Bristol Myers Squibb Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes · 501d
Method
›
Moved together
ABBV
with
BMY
×0.46
co-movement · BMY on ABBV · 501d
r 0.43
scale to r 0.75
Shared co-movers
8
with ABBV
with BMY
AMGN
Amgen Inc
r 0.52
r 0.52
MRK
Merck & Co., Inc.
r 0.51
r 0.52
NVS
Novartis AG
r 0.48
r 0.49
PFE
Pfizer Inc
r 0.48
r 0.58
JNJ
Johnson & Johnson
r 0.45
r 0.43
BIIB
Biogen Inc.
r 0.43
r 0.45
ABBV, solid
BMY, hatched
× = co-movement · β
r = correlation
Bar = r to r 0.75
Order: weaker of A and B
Source: daily closes
ABBV
AbbVie Inc.
Change
290.92
▲
+0.93%
· post 291.30
Mkt cap
$509.5B
Revenue
$17.4B
Q3 FY26
Revenue
$61.2B
FY25
BMY
Bristol Myers Squibb Co
Change
62.15
▼
−1.55%
· post 62.30
Closed
Nov 6 '26
Mkt cap
$127.0B
Revenue
$13.1B
Q3 FY26
Revenue
$48.2B
FY25
vs
Compare
Closed
Nov 6 '26
ABBV
AbbVie Inc.
vs
BMY
Bristol Myers Squibb Co
290.92
▲
+0.93%
post 291.30
Price
62.15
▼
−1.55%
post 62.30
$509.5B
Mkt cap
$127.0B
Q3 FY26
$17.4B
Revenue
$13.1B
Q3 FY26
FY25
$61.2B
Revenue
$48.2B
FY25
Change
Change
ABBV
290.92
▲
+0.93%
vs
BMY
62.15
▼
−1.55%
Closed
Nov 6 '26